{"disease":{"id":"herpes-simplex-2","name":"herpes simplex 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01681420","title":"Improving Blood Safety and HIV Testing in Brazil","phase":"NA","overall_status":"COMPLETED","enrollment_count":11900,"lead_sponsor_name":"Vitalant Research Institute","has_results":false},{"nct_id":"NCT05452928","title":"Aciclovir Versus Placebo for HSV-2 Meningitis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Jacob Bodilsen","has_results":false},{"nct_id":"NCT02910284","title":"Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Genocea Biosciences, Inc.","has_results":false},{"nct_id":"NCT03282916","title":"Anti-viral Therapy in Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT06385327","title":"A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Assembly Biosciences","has_results":false},{"nct_id":"NCT06698575","title":"A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Assembly Biosciences","has_results":false},{"nct_id":"NCT04710030","title":"Valacyclovir for Mild Cognitive Impairment","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":true},{"nct_id":"NCT05823779","title":"A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Global Research Institute","has_results":false},{"nct_id":"NCT04664127","title":"Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Nearmedic Plus LLC","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}